Myelodysplastic Syndromes

Showing NaN - NaN of 60

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)

    Completed
    • Myelodysplastic Syndromes
    • +2 more
    • Augusta, Georgia
    • +37 more
    Jul 20, 2020

    MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    Jun 29, 2020

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    MDS Trial in Boston, New York (Tipifarnib)

    Terminated
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
    • +1 more
    Jan 30, 2020

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Withdrawn
    • Leukemia
    • +4 more
    • alemtuzumab
    • +6 more
    • La Jolla, California
    • +23 more
    Nov 25, 2019

    MDS Trial in Germany, United States (lenalidomide)

    Completed
    • Myelodysplastic Syndromes
    • Scottsdale, Arizona
    • +31 more
    Nov 6, 2019

    MDS Trial in United States (Atezolizumab, Azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • Duarte, California
    • +14 more
    Aug 15, 2019

    Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • +7 more
    • Los Angeles, California
    • +5 more
    Jul 1, 2019

    Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)

    Terminated
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jun 10, 2019

    Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)

    Terminated
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Phoenix, Arizona
    • +5 more
    Oct 17, 2018

    Acute Myeloid Leukemia, MDS Trial in Boston, New York (RO6870810)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
    • +1 more
    Dec 7, 2017

    Beta-thalassemia, MDS, Fanconi Syndrome Trial in United States (Deferasirox)

    Completed
    • Beta-thalassemia
    • +4 more
    • Oakland, California
    • +5 more
    Aug 17, 2017

    Acute Myeloid Leukemia, MDS Trial in Los Angeles, Boston, New York (Itraconazole, PKC412)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Los Angeles, California
    • +3 more
    Aug 7, 2017

    Leukemia, Acute Disease, Acute Myeloid Leukemia Trial in United States (vosaroxin)

    Completed
    • Leukemia
    • +4 more
    • Phoenix, Arizona
    • +19 more
    May 25, 2017

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Boston (drug, procedure, radiation)

    Completed
    • Chronic Myeloproliferative Disorders
    • +6 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 20, 2017

    GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)

    Completed
    • Graft Versus Host Disease
    • +4 more
    • Boston, Massachusetts
    • +1 more
    Mar 30, 2017

    Leukemia, MDS Trial in United States (topotecan HCl)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • topotecan hydrochloride
    • Birmingham, Alabama
    • +47 more
    Jul 19, 2016

    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in France, United States

    Completed
    • Leukemia, Myelocytic, Acute
    • +3 more
    • Duarte, California
    • +23 more
    Feb 8, 2016

    Bone Marrow Transplantation, Blood Disease, Hematopoietic Stem Cell Transplantation Trial in United States (fluconazole,

    Completed
    • Bone Marrow Transplantation
    • +6 more
    • Duarte, California
    • +15 more
    Feb 17, 2016

    Anemia, MDS Trial in United States (Erythropoietin, Filgrastim, Transfusion)

    Completed
    • Anemia
    • Myelodysplastic Syndromes
    • Erythropoietin
    • +2 more
    • Denver, Colorado
    • +27 more
    Oct 6, 2015

    Leukemia, MDS Trial in Israel, United States (filgrastim, sargramostim, cytarabine)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • filgrastim
    • +5 more
    • Scottsdale, Arizona
    • +91 more
    Jun 1, 2015

    Leukemia, MDS Trial in Canada, United States (drug, procedure, radiation)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • Phoenix, Arizona
    • +65 more
    Mar 5, 2015

    Leukemia, MDS Trial in United States (anti-thymocyte globulin, cyclosporine)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • Mobile, Alabama
    • +93 more
    Mar 5, 2015